Prevention and care of stroke in low- and middle-income countries; the need for a public health perspective

International Journal of Stroke

Volumn 5, Issue 2, 2010, Pages 86-91

  Mendis, S ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Low and middle income countries; Primary prevention; Public health perspective; Secondary prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT;

ARTICLE; ATHEROSCLEROSIS; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAREGIVER SUPPORT; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; DECOMPRESSION SURGERY; DISEASE CLASSIFICATION; DRUG COST; DRUG FATALITY; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE NEED; HIGH RISK POPULATION; HUMAN; IMMOBILIZATION; LIFESTYLE MODIFICATION; LOWEST INCOME GROUP; MEDICAL EDUCATION; PATIENT CARE; PATIENT EDUCATION; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; SECONDARY PREVENTION; SMOKING HABIT; SODIUM RESTRICTION; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; COST OF ILLNESS; FOLLOW-UP STUDIES; HEART DISEASES; INCIDENCE; INCOME; ISCHEMIC ATTACK, TRANSIENT; POVERTY; PRIMARY PREVENTION; PUBLIC HEALTH; RISK FACTORS; STROKE; WORLD HEALTH;

EID: 77951248831     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00406.x     Document Type: Article

References (45)

1. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis 2009, 27:493-501.
2. The Global Burden of Disease: 2004 Update 2008, World Health Organization., Geneva, World Health Organization
3. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8:355-69.
4. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modeling. Lancet Neurol 2009, 8:345-54.
5. Colin DM, Dejan L. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
6. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007, 6:182-7.
7. Ezzati M, Vander Hoorn S, Rodgers A, Lopez AD, Mathers CD, Murray CJ. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003, 362:271-80.
8. Menon U, Kelley RE. Subcortical ischemic cerebrovascular dementia. Int Rev Neurobiol 2009, 84:21-33.
9. The World Health Report 2002 Reducing Risks; Promoting Health Life 2002, World Health Organization., Geneva, World Health Organization
10. Prevention of Cardiovascular Disease. Guidelines for Assessment and Management of Cardiovascular Risk 2007, World Health Organization., Geneva, World Health Organization
11. Prevention of Recurrent Heart Attacks and Strokes in Low and Middle-Income Populations. Evidence-Based Recommendations for Policy Makers and Health Professionals 2003, World Health Organization., Geneva, Switzerland, World Health Organization
12. Heller RF, Langhorne P, James E. Improving stroke outcome: the benefits of increasing availability of technology. Bull World Health Organ 2000, 78:1337-43.
13. Lindholm LH, Mendis S. Prevention of cardiovascular disease in developing countries. Lancet 2007, 370:720-2.
14. Mendis S, Fuster V. National policies and strategies for noncommunicable diseases. Rev Cardiol 2009, 6:723-7.
15. Global Strategy for the Prevention and Control of Noncommunicable Diseases (NCDs) (WHA A53/14) 2000, World Health Assembly., Geneva, World Health Organization
16. Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases (NCDs) (WHA A61/8) 2008, World Health Assembly., Geneva, World Health Organization
17. Conference of the Parties to the WHO Framework Convention on Tobacco Control 2007, http://www.who.int/gb/fctc/PDF/cop2/FCTC_COP2_17P-en.pdf, World Health Organization., Geneva, World Health Organization, Available at
18. Global Strategy on Diet, Physical Activity and Health 2004, World Health Organization., Geneva, World Health Organization
19. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004, 3:CD004937.
20. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2008, http://www.nature.com/jhh/journal/vaop/ncurrent/abs/jhh2008144a.html, Available at
21. Reducing Salt Intake in Populations: Report of A WHO Forum and Technical Meeting, 5-7 October 2006 2007, http://www.who.int/dietphysicalactivity/reducingsaltintake_EN.pdf, World Health Organization., Paris, France, World Health Organization, Available at
22. Dickinson BD, Havas S. Reducing the population burden of cardiovascular disease by reducing sodium intake: a report of the Council on Science and Public Health. Arch Intern Med 2007, 167:1460-8.
23. Weber R, Weimar C, Diener HC. Antiplatelet agents in stroke prevention. Hamostaseologie 2009, 29:326-33.
24. Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 150:405-10.
25. De Berardis G, Sacco M, Strippoli GF. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomized controlled trials. BMJ 2009, 339:1210-11.
26. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008, 371:1612-23.
27. Chen ZM, Sandercock P, Pan HC. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 2000, 31:1240-9.
28. Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003, 3:CD000213.
29. Verro P, Gorelick PB, Nguyen D. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. Stroke 2008, 39:1076-7.
30. Gommans J, Barber PA, Fink J. Preventing strokes: the assessment and management of people with transient ischaemic attack. N Z Med J 2009, 122:3556.
31. Ezekowitz MD, Koti MJ, Fulton B. Reducing stroke rates in patients with atrial fibrillation: how low can we go? Circulation 2009, 120:1169-70.
32. Mant J, Hobbs FD. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007, 370:493-503. for the BAFTA Investigators, Midland Research Practices Network (MidReC)
33. Connolly S, Pogue J. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006, 367:1903-12. for the ACTIVE Writing Group of the ACTIVE Investigators
34. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007, 4:CD000197. Stroke Unit Trialists ' Collaboration, review
35. Walker RW, McLarty DG, Kitange HM. Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet 2000, 355:1684-7.
36. Jacques J, Louise FP, Thierry M. Stroke in rural areas and small communities. Stroke 2008, 39:1920-28.
37. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001, 32:1832-40.
38. http://www.ircst.health.nsw.gov.au, NSW Rural Health Rural Stroke Project, Available at, (accessed October 2007)
39. Brainin M, Teuschl Y, Karla L. Acute treatment and long-term management of stroke in developing countries. Lancet Neurol 2007, 6:553-61.
40. The World Health Report 2006. Working Together for Health 2006, World Health Organization., Geneva, World Health Organization
41. Sudlow C, Warlow C. Getting the priorities right for stroke care. BMJ 2009, 338:1419-22.
42. Garbusinski JM, van der Sande MA, Bartholome EJ. Stroke presentation and outcome in developing countries: a prospective study in the Gambia. Stroke 2005, 36:1388-93.
43. Hess DC, Wang S, Hamilton W. REACH: clinical feasibility of a rural telestroke network. Stroke 2005, 36:2018-20.
44. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low Resource Settings 2009, World Health Organization., Geneva, World Health Organization
45. Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL. Telemedic Pilot Project for Integrative Stroke Care Group: effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol 2006, 5:742-8.